pimobendan has been researched along with Ventricular Fibrillation in 1 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lynch, JJ | 1 |
Kitzen, JM | 1 |
Hoff, PT | 1 |
Lucchesi, BR | 1 |
1 other study available for pimobendan and Ventricular Fibrillation
Article | Year |
---|---|
Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
Topics: Animals; Cardiotonic Agents; Death, Sudden; Dogs; Electric Stimulation; Electrophysiology; Female; H | 1988 |